Meeting
2021 ASCO Annual Meeting
DNA and RNA sequencing analysis revealed alterations of ANK3, PKHD1 and olfactory transduction as potential biomarker of three-year survival in gastric cancer.
Authors
Jian Wang
Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjinng, China
Jian Wang , Si Li , Wenjing Xi , Dongsheng Chen , Mingzhe Xiao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4034)
DOI
10.1200/JCO.2021.39.15_suppl.4034
Abstract #
4034
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of intensifying supportive care with improved survival in patients with gastric cancer with malignant ascites.
First Author: John D Karalis
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The effects of pre-existing psychiatric disorders on gastric cancer survival.
First Author: Josephine Soddano
Poster
2023 ASCO Annual Meeting
The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.
First Author: Jhanelle Elaine Gray
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
First Author: Kevin R Reyes